Dr. Deepa Jeyakumar
Claim this profileUC Irvine Health/Chao Family Comprehensive Cancer Center
About Deepa Jeyakumar
Education:
- Earned a Medical degree (MD) from an unspecified institution.
Experience:
- Specializes in hematologic malignancies, with a focus on acute myeloid leukemia.
- Serves as Co-leader of the Hematologic Malignancies Disease Oriented Team at UCI School of Medicine.
- Affiliated with UCI Health Chao Family Comprehensive Cancer Center, an NCI-designated comprehensive cancer center.
- Active participant in the Southwest Oncology Group (SWOG) for NCI-funded clinical trials.
- Involved in the University of California's collaborative efforts for early phase and investigator-initiated clinical studies.
Area of expertise
Acute Myelogenous Leukemia
Deepa Jeyakumar has run 12 trials for Acute Myelogenous Leukemia. Some of their research focus areas include:
Acute Myeloid Leukemia
Deepa Jeyakumar has run 11 trials for Acute Myeloid Leukemia. Some of their research focus areas include:
Affiliated Hospitals
UC Irvine Health/Chao Family Comprehensive Cancer Center
University Of California, Irvine
Clinical Trials Deepa Jeyakumar is currently running
Blinatumomab + Chemotherapy
for Leukemia
This phase III trial compares the effect of usual treatment of chemotherapy and steroids and a tyrosine kinase inhibitor (TKI) to the same treatment plus blinatumomab. Blinatumomab is a Bi-specific T-Cell Engager ('BiTE') that may interfere with the ability of cancer cells to grow and spread. The information gained from this study may help researchers determine if combination therapy with steroids, TKIs, and blinatumomab work better than the standard of care.
Recruiting
2 awards
Phase 3
10 criteria
DFP-10917
for Acute Myeloid Leukemia
Phase III, multicenter, randomized study with two arms (1:1 ratio) enrolling patients with AML relapsed/refractory after 2, 3, or 4 prior induction regimens: Experimental arm: DFP-10917 14-day continuous intravenous (IV) infusion at a dose of 6 mg/m²/day followed by a 14-day resting period per 28-day cycles. Control arm: Non-Intensive Reinduction (LoDAC, Azacitidine, Decitabine, Venetoclax Combination Regimens) or Intensive Reinduction (High and Intermediate Dose Cytarabine Regimens), depending on the patient's prior induction treatment.
Recruiting
2 awards
Phase 3
4 criteria
More about Deepa Jeyakumar
Clinical Trial Related
4 years of experience running clinical trials · Led 20 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments Deepa Jeyakumar has experience with
- Cytarabine
- Venetoclax
- Azacitidine
- Blinatumomab
- Pembrolizumab
- Dexamethasone
Breakdown of trials Deepa Jeyakumar has run
Acute Myelogenous Leukemia
Acute Myeloid Leukemia
Myelodysplastic Syndrome
Relapse
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Deepa Jeyakumar specialize in?
Deepa Jeyakumar focuses on Acute Myelogenous Leukemia and Acute Myeloid Leukemia. In particular, much of their work with Acute Myelogenous Leukemia has involved IDH positive patients, or patients who are FLT3 positive.
Is Deepa Jeyakumar currently recruiting for clinical trials?
Yes, Deepa Jeyakumar is currently recruiting for 4 clinical trials in Orange California. If you're interested in participating, you should apply.
Are there any treatments that Deepa Jeyakumar has studied deeply?
Yes, Deepa Jeyakumar has studied treatments such as Cytarabine, Venetoclax, Azacitidine.
What is the best way to schedule an appointment with Deepa Jeyakumar?
Apply for one of the trials that Deepa Jeyakumar is conducting.
What is the office address of Deepa Jeyakumar?
The office of Deepa Jeyakumar is located at: UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California 92868 United States. This is the address for their practice at the UC Irvine Health/Chao Family Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.